BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

889 related articles for article (PubMed ID: 12202516)

  • 21. The expression of heat shock protein 27 in retinal ganglion and glial cells in a rat glaucoma model.
    Kalesnykas G; Niittykoski M; Rantala J; Miettinen R; Salminen A; Kaarniranta K; Uusitalo H
    Neuroscience; 2007 Dec; 150(3):692-704. PubMed ID: 17993247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melanopsin-expressing retinal ganglion cells are more injury-resistant in a chronic ocular hypertension model.
    Li RS; Chen BY; Tay DK; Chan HH; Pu ML; So KF
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2951-8. PubMed ID: 16799038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma.
    Jiang C; Moore MJ; Zhang X; Klassen H; Langer R; Young M
    Mol Vis; 2007 Sep; 13():1783-92. PubMed ID: 17960131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma.
    Hains BC; Waxman SG
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4164-9. PubMed ID: 16249495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective excitotoxic degeneration of adult pig retinal ganglion cells in vitro.
    Luo X; Heidinger V; Picaud S; Lambrou G; Dreyfus H; Sahel J; Hicks D
    Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):1096-106. PubMed ID: 11274091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of heat shock protein 72 protects retinal ganglion cells in a rat glaucoma model.
    Park KH; Cozier F; Ong OC; Caprioli J
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1522-30. PubMed ID: 11381056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brn3a as a marker of retinal ganglion cells: qualitative and quantitative time course studies in naive and optic nerve-injured retinas.
    Nadal-Nicolás FM; Jiménez-López M; Sobrado-Calvo P; Nieto-López L; Cánovas-Martínez I; Salinas-Navarro M; Vidal-Sanz M; Agudo M
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3860-8. PubMed ID: 19264888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinal ganglion cell death after different transient periods of pressure-induced ischemia and survival intervals. A quantitative in vivo study.
    Sellés-Navarro I; Villegas-Pérez MP; Salvador-Silva M; Ruiz-Gómez JM; Vidal-Sanz M
    Invest Ophthalmol Vis Sci; 1996 Sep; 37(10):2002-14. PubMed ID: 8814140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The expression of heat shock protein 27 in retinal ganglion cells in the rat glaucoma model].
    Lü HB; Yuan YS; Li Y; Li J
    Zhonghua Yan Ke Za Zhi; 2005 Jun; 41(6):533-9. PubMed ID: 16008915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinal ganglion cell neuroprotection in a rat model of glaucoma following brimonidine, latanoprost or combined treatments.
    Hernández M; Urcola JH; Vecino E
    Exp Eye Res; 2008 May; 86(5):798-806. PubMed ID: 18394603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optic nerve dynein motor protein distribution changes with intraocular pressure elevation in a rat model of glaucoma.
    Martin KR; Quigley HA; Valenta D; Kielczewski J; Pease ME
    Exp Eye Res; 2006 Aug; 83(2):255-62. PubMed ID: 16546168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional assessment of glutamate clearance mechanisms in a chronic rat glaucoma model using retinal ganglion cell calcium imaging.
    Hartwick AT; Zhang X; Chauhan BC; Baldridge WH
    J Neurochem; 2005 Aug; 94(3):794-807. PubMed ID: 16001970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downregulation of Thy1 in retinal ganglion cells in experimental glaucoma.
    Huang W; Fileta J; Guo Y; Grosskreutz CL
    Curr Eye Res; 2006 Mar; 31(3):265-71. PubMed ID: 16531284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A rat model for acute rise in intraocular pressure: immune modulation as a therapeutic strategy.
    Ben Simon GJ; Bakalash S; Aloni E; Rosner M
    Am J Ophthalmol; 2006 Jun; 141(6):1105-11. PubMed ID: 16765680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ocular hypotensive effects of topically administered agmatine in a chronic ocular hypertensive rat model.
    Hong S; Kim CY; Lee WS; Shim J; Yeom HY; Seong GJ
    Exp Eye Res; 2010 Jan; 90(1):97-103. PubMed ID: 19782071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of intraocular pressure elevation in a modified laser-induced glaucoma rat model.
    Biermann J; van Oterendorp C; Stoykow C; Volz C; Jehle T; Boehringer D; Lagrèze WA
    Exp Eye Res; 2012 Nov; 104():7-14. PubMed ID: 22981807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective inner retinal dysfunction precedes ganglion cell loss in a mouse glaucoma model.
    Holcombe DJ; Lengefeld N; Gole GA; Barnett NL
    Br J Ophthalmol; 2008 May; 92(5):683-8. PubMed ID: 18296504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mouse model of sustained elevation in intraocular pressure produced by episcleral vein occlusion.
    Ruiz-Ederra J; Verkman AS
    Exp Eye Res; 2006 May; 82(5):879-84. PubMed ID: 16310189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The transcription factor c-jun is activated in retinal ganglion cells in experimental rat glaucoma.
    Levkovitch-Verbin H; Quigley HA; Martin KR; Harizman N; Valenta DF; Pease ME; Melamed S
    Exp Eye Res; 2005 May; 80(5):663-70. PubMed ID: 15862173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topically administered timolol and dorzolamide reduce intraocular pressure and protect retinal ganglion cells in a rat experimental glaucoma model.
    Seki M; Tanaka T; Matsuda H; Togano T; Hashimoto K; Ueda J; Fukuchi T; Abe H
    Br J Ophthalmol; 2005 Apr; 89(4):504-7. PubMed ID: 15774933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.